Japanische Biotechnologie in Deutschland
Article Abstract:
In cooperation with a partner, the Japanese Tokyo-based pharmaceutical company Chugai Pharma is to launch a biopharmaceutical product in Germany. A marketing organisation is to be set up in Frankfurt. At present, Chugai is marketing two biopharmaceutical medicines, the granylocyte-colony-stimulating "Neutrogin" (in Europe available as "Granocyte") and the erythropoietin "Epogin" (not available in Europe), which contributed altogether 591mn to the pharmaceutical company's total turnover of 185.6bn in 1997.
Comment:
To launch a biopharmaceutical product in Germany in cooperation with a partner
Publication Name: Europa Chemie
Subject: Chemicals, plastics and rubber industries
ISSN: 0014-2484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
GERMANY: MEISSNER & WURST WIN INSULIN PLANT JOB
Article Abstract:
Hoechst Marion Roussel (HMR) of Frankfurt and Pfizer Inc. of New York have placed a contract with Stuttgart-based Life Sciences Meissner & Wurst GmbH (LSMW) for the planning of the world's biggest insulin production plant by mid-1999. The plant to be built in Hoechst, Frankfurt, will produce inhalable insulin. The contract that is worth a double-digit million amount includes an option for the construction of the plant. LSMW is a joint venture of German M & W Zander and Day & Zimmermann of the US.
Publication Name: Europa Chemie
Subject: Chemicals, plastics and rubber industries
ISSN: 0014-2484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
AUSTRIA: BIOCHEMIE EXPANDING OVERSEAS
Article Abstract:
Austrian Biochemie of Kundl, a subsidiary of Novartis and a leading producer of antibiotics worldwide, is investigating investment opportunities in Latin America. For 1999 Biochemie is expecting a 5% increase in sales from Sch 9.936bn in 1998, to which exports contributed 96.8%. In future turnover is grow by Sch 1bn annually. Biochemie is spending Sch 100mn on a research facility in India, which is to be completed in two years.
Publication Name: Europa Chemie
Subject: Chemicals, plastics and rubber industries
ISSN: 0014-2484
Year: 1999
User Contributions:
Comment about this article or add new information about this topic: